Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Extra funding for Canadian cervical cancer network:

This article was originally published in Clinica

Executive Summary

The Canadian government is to give Can$670,000 ($482,000) over three years to support the country's cervical cancer network. The funds will be given to the Cervical Cancer Prevention Network and the Nova Scotia Gynaecological Cancer Screening Programme, which will divide the money between a collaborative project and a pilot study. Some 35% of Canadian women aged 18-24 and almost 30% of women over 65 have never been screened for cervical cancer. Each year, over 200,000 pre-cancerous cervical abnormalities are reported in Canada.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT084307

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel